info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0141159 |
| CAS No | NA |
| Mol.F. | C24H26N2O3 |
| Mol.Wt. | 390.48 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141160 |
| CAS No | NA |
| Mol.F. | C13H7F3N2OS |
| Mol.Wt. | 296.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141161 |
| CAS No | NA |
| Mol.F. | C8H13N5O |
| Mol.Wt. | 195.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141162 |
| CAS No | NA |
| Mol.F. | C8H12N6O2 |
| Mol.Wt. | 224.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141163 |
| CAS No | NA |
| Mol.F. | C20H19N3O4 |
| Mol.Wt. | 365.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141164 |
| CAS No | NA |
| Mol.F. | C4H8N4O2 |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141165 |
| CAS No | NA |
| Mol.F. | C8H5N5O6 |
| Mol.Wt. | 267.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141166 |
| CAS No | NA |
| Mol.F. | C25H26N10O4 |
| Mol.Wt. | 530.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141167 |
| CAS No | NA |
| Mol.F. | C25H27N9O3 |
| Mol.Wt. | 501.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141168 |
| CAS No | NA |
| Mol.F. | C51H55N17O5 |
| Mol.Wt. | 986.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141169 |
| CAS No | NA |
| Mol.F. | C51H54N18O6 |
| Mol.Wt. | 1015.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141170 |
| CAS No | NA |
| Mol.F. | C10H19N3O3 |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141171 |
| CAS No | NA |
| Mol.F. | C51H55N17O5 |
| Mol.Wt. | 986.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141172 |
| CAS No | NA |
| Mol.F. | C21H20N8O3 |
| Mol.Wt. | 432.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141173 |
| CAS No | NA |
| Mol.F. | C45H43N15O5 |
| Mol.Wt. | 873.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141174 |
| CAS No | NA |
| Mol.F. | C21H23N9O3 |
| Mol.Wt. | 449.5 |
| INV STATUS | CUSTOM SYNTHESIS |
